Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Caterina Aversa
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
Cancer Research
Cancer Research
Oncology
Dancing With the DNA Damage Response: Next-Generation Anti-Cancer Therapeutic Strategies
Therapeutic Advances in Medical Oncology
Oncology
Related publications
Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
PSMA Redirects MAPK to PI3K-AKT Signaling to Promote Prostate Cancer Progression
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Collateral Resistance to Taxanes in Enzalutamide-Resistant Prostate Cancer Through Aberrant Androgen Receptor and Its Variants
Cancer Science
Cancer Research
Medicine
Oncology
Eyeing Enzalutamide for Hormone-Sensitive Prostate Cancer
Cancer Discovery
Oncology
Melanocytic Signaling Promotes Resistance to MAPK Inhibition
Cancer Discovery
Oncology
Activation of MAPK Signaling Pathway Is Essential for Id-1 Induced Serum Independent Prostate Cancer Cell Growth
Oncogene
Cancer Research
Genetics
Molecular Biology
Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
Clinical Medicine Insights: Oncology
Oncology
Wedelolactone, an Anti-Inflammatory Botanical, Interrupts C-Myc Oncogenic Signaling and Synergizes With Enzalutamide to Induce Apoptosis in Prostate Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
MYH9 Promotes Growth and Metastasis via Activation of MAPK/AKT Signaling in Colorectal Cancer
Journal of Cancer
Oncology
